BioFish Holding AS
Oslo Stock ExchangeTotal Valuation
BioFish Holding AS carries a market capitalization of 197.08M, placing it among publicly traded companies globally. Its enterprise value stands at 204.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 197.08M |
| Enterprise Value | 204.30M |
Share Statistics
BioFish Holding AS currently has 111.98M shares outstanding.
| Shares Outstanding | 111.98M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.20, and the price-to-book ratio stands at 0.77.
| PE Ratio | N/A |
| PS Ratio | 2.20 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | 14.61 |
| P/OCF Ratio | -24.63 |
Enterprise Valuation
| EV / Sales | 3.09 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 11.48 |
Financial Position
BioFish Holding AS maintains a current ratio of 0.91, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.60, indicating elevated leverage, while an interest coverage ratio of -1.56 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.91 |
| Quick Ratio | 0.27 |
| Debt / Equity | 35.60 |
| Debt / EBITDA | -5.63 |
| Interest Coverage | -1.56 |
Financial Efficiency
| Return on Equity (ROE) | -10.21 |
| Return on Assets (ROA) | -7.34 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -1.30 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.67 |
Stock Price Statistics
BioFish Holding AS's stock has gained approximately 54.38596% over the past 52 weeks. The 50-day moving average sits at 1.74, while the 200-day moving average is 1.41.
| Beta (5Y) | N/A |
| 52-Week Price Change | 54.38596% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 1.41 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, BioFish Holding AS generated 66.19M in revenue and converted that into -20.09M in net income, yielding earnings per share of -0.19. EBITDA reached -12.25M, while operating income came in at -12.25M.
| Revenue | 66.19M |
| Gross Profit | 23.56M |
| Operating Income | -12.25M |
| Pretax Income | -20.09M |
| Net Income | -20.09M |
| EBITDA | -12.25M |
| EBIT | -12.25M |
| Earnings Per Share (EPS) | -0.19 |
Balance Sheet
BioFish Holding AS holds 10.13M in cash and equivalents against 68.95M in total debt, resulting in a net debt position of 58.82M. Total book value stands at 188.03M, with working capital of -3.29M providing operational flexibility.
| Cash & Cash Equivalents | 10.13M |
| Total Debt | 68.95M |
| Net Debt | 58.82M |
| Equity (Book Value) | 188.03M |
| Book Value Per Share | 1.73 |
| Working Capital | -3.29M |
Cash Flow
BioFish Holding AS produced -5.91M in operating cash flow over the past twelve months. After subtracting -15.86M in capital expenditures, free cash flow totaled -21.77M - equivalent to -0.20 per share.
| Operating Cash Flow | -5.91M |
| Capital Expenditures | -15.86M |
| Free Cash Flow | -21.77M |
| FCF Per Share | -0.20 |
Margins
BioFish Holding AS operates with a gross margin of 35.59, reflecting its pricing power and cost economics. The operating margin of -18.51 and net profit margin of -30.35 provide insight into operational efficiency.
| Gross Margin | 35.59 |
| Operating Margin | -18.51 |
| Pretax Margin | -30.35 |
| Profit Margin | -30.35 |
| EBITDA Margin | -18.51 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -9.64 |
| FCF Yield | 6.84 |
Stock Splits
BioFish Holding AS's most recent stock split took place on January 13, 2023 with a 1000:1457 split ratio.
| Last Split Date | 1/13/2023 |
| Split Ratio | 1000:1457 |
Scores
BioFish Holding AS posts an Altman Z-Score of 1.11, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.11 |